ストックスクリーナーアプリを入手
125.27
1.07%
-1.37
アフターアワーズ：
125.27
前日終値:
$126.64
開ける：
$126.96
24時間の取引高:
5.21M
Relative Volume:
0.74
時価総額：
$155.38B
収益：
$29.05B
当期純損益:
$8.11B
株価収益率:
19.40
EPS:
6.4563
ネットキャッシュフロー:
$9.16B
1週間 パフォーマンス:
+0.97%
1か月 パフォーマンス:
+3.60%
6か月 パフォーマンス:
+16.69%
1年 パフォーマンス:
+38.92%
1日の値動き範囲:
$124.49
$128.25
1週間の範囲:
$123.32
$128.70
52週間の値動き範囲:
$88.57
$128.70
Gilead Sciences Inc Stock (GILD) Company Profile
GILD を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
GILD
Gilead Sciences Inc
|
125.24 | 157.12B | 29.05B | 8.11B | 9.16B | 6.4563 |
|
LLY
Lilly Eli Co
|
1,070.16 | 948.45B | 59.42B | 18.41B | 6.44B | 20.22 |
|
JNJ
Johnson Johnson
|
205.92 | 491.26B | 92.15B | 25.12B | 20.46B | 10.36 |
|
ABBV
Abbvie Inc
|
229.45 | 417.60B | 59.64B | 2.36B | 19.68B | 1.3253 |
|
NVS
Novartis Ag Adr
|
126.53 | 244.28B | 54.45B | 14.42B | 17.15B | 7.333 |
|
MRK
Merck Co Inc
|
100.42 | 242.64B | 63.90B | 19.05B | 13.05B | 7.5596 |
Gilead Sciences Inc Stock (GILD) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-11-13 | 開始されました | Scotiabank | Sector Outperform |
| 2025-08-19 | アップグレード | Daiwa Securities | Neutral → Outperform |
| 2025-08-08 | アップグレード | Truist | Hold → Buy |
| 2025-07-25 | アップグレード | Needham | Hold → Buy |
| 2025-04-22 | 再開されました | Cantor Fitzgerald | Overweight |
| 2025-03-04 | 繰り返されました | Oppenheimer | Outperform |
| 2025-02-18 | アップグレード | Deutsche Bank | Hold → Buy |
| 2025-02-13 | アップグレード | DZ Bank | Hold → Buy |
| 2025-01-10 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2024-12-10 | 再開されました | BofA Securities | Buy |
| 2024-11-15 | 開始されました | Wolfe Research | Outperform |
| 2024-11-14 | 開始されました | Citigroup | Buy |
| 2024-11-08 | ダウングレード | Maxim Group | Buy → Hold |
| 2024-10-21 | アップグレード | Leerink Partners | Market Perform → Outperform |
| 2024-10-17 | 開始されました | Bernstein | Outperform |
| 2024-10-07 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2024-07-08 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2024-05-01 | 繰り返されました | Maxim Group | Buy |
| 2024-04-24 | アップグレード | HSBC Securities | Reduce → Hold |
| 2024-02-22 | ダウングレード | Truist | Buy → Hold |
| 2023-11-09 | 開始されました | Deutsche Bank | Hold |
| 2023-09-08 | アップグレード | BofA Securities | Neutral → Buy |
| 2023-09-06 | 開始されました | HSBC Securities | Reduce |
| 2023-07-24 | 繰り返されました | Barclays | Equal Weight |
| 2023-05-16 | アップグレード | BMO Capital Markets | Market Perform → Outperform |
| 2023-04-28 | 再開されました | Piper Sandler | Overweight |
| 2023-01-03 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-12-13 | 再開されました | BofA Securities | Neutral |
| 2022-12-09 | ダウングレード | DZ Bank | Buy → Hold |
| 2022-10-31 | アップグレード | Barclays | Underweight → Equal Weight |
| 2022-10-28 | 繰り返されました | BMO Capital Markets | Market Perform |
| 2022-10-28 | 繰り返されました | Cowen | Outperform |
| 2022-10-28 | 繰り返されました | JP Morgan | Overweight |
| 2022-10-28 | 繰り返されました | Jefferies | Buy |
| 2022-10-28 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2022-10-28 | 繰り返されました | RBC Capital Mkts | Outperform |
| 2022-10-28 | アップグレード | Truist | Hold → Buy |
| 2022-10-28 | 繰り返されました | Wells Fargo | Equal Weight |
| 2022-10-04 | アップグレード | JP Morgan | Neutral → Overweight |
| 2022-07-13 | 開始されました | Cantor Fitzgerald | Neutral |
| 2022-05-23 | 開始されました | SVB Leerink | Mkt Perform |
| 2022-02-28 | ダウングレード | BMO Capital Markets | Outperform → Market Perform |
| 2022-02-02 | 繰り返されました | BMO Capital Markets | Outperform |
| 2022-02-02 | 繰り返されました | BofA Securities | Neutral |
| 2022-02-02 | 繰り返されました | RBC Capital Mkts | Outperform |
| 2022-02-02 | 繰り返されました | Truist | Hold |
| 2022-02-02 | 繰り返されました | Wells Fargo | Equal Weight |
| 2022-01-28 | アップグレード | Argus | Hold → Buy |
| 2022-01-06 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2021-12-09 | 再開されました | Wells Fargo | Equal Weight |
| 2021-12-06 | 開始されました | Goldman | Neutral |
| 2021-11-19 | アップグレード | BMO Capital Markets | Market Perform → Outperform |
| 2021-11-19 | 再開されました | Piper Sandler | Neutral |
| 2021-10-20 | 再開されました | Cowen | Outperform |
| 2021-07-30 | 繰り返されました | BMO Capital Markets | Market Perform |
| 2021-07-30 | 繰り返されました | RBC Capital Mkts | Outperform |
| 2021-04-01 | アップグレード | Bernstein | Mkt Perform → Outperform |
| 2021-03-30 | アップグレード | Redburn | Neutral → Buy |
| 2021-01-19 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2021-01-04 | アップグレード | Guggenheim | Neutral → Buy |
| 2020-11-03 | 再開されました | Morgan Stanley | Equal-Weight |
| 2020-10-28 | 開始されました | UBS | Neutral |
| 2020-09-30 | 再開されました | Jefferies | Buy |
| 2020-09-15 | アップグレード | Maxim Group | Hold → Buy |
| 2020-07-31 | 繰り返されました | Credit Suisse | Neutral |
| 2020-07-31 | 繰り返されました | Morgan Stanley | Equal-Weight |
| 2020-07-31 | 繰り返されました | Piper Sandler | Overweight |
| 2020-07-31 | 繰り返されました | RBC Capital Mkts | Outperform |
| 2020-07-31 | 繰り返されました | SunTrust | Hold |
| 2020-07-31 | 繰り返されました | Wells Fargo | Equal Weight |
| 2020-07-20 | アップグレード | Credit Suisse | Underperform → Neutral |
| 2020-06-03 | アップグレード | SVB Leerink | Mkt Perform → Outperform |
| 2020-05-26 | アップグレード | SunTrust | Sell → Hold |
| 2020-05-01 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2020-05-01 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2020-05-01 | ダウングレード | SunTrust | Hold → Sell |
| 2020-04-27 | ダウングレード | UBS | Buy → Neutral |
| 2020-04-20 | ダウングレード | BMO Capital Markets | Outperform → Market Perform |
| 2020-04-20 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2020-04-17 | ダウングレード | CFRA | Hold → Sell |
すべてを表示
Gilead Sciences Inc (GILD) 最新ニュース
GILD: Truist Securities Lowers Price Target for Gilead Sciences - GuruFocus
From the Lab to Runway: HIV Unwrapped Helps Transform Stigma by Giving Lab Coats a Makeover - Gilead Sciences
BioStock: Sprint Bioscience sells cancer program TREX1 to Gilead - TradingView
Prudential Financial Inc. Buys 486,379 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Gilead Foundation Commits Over $3 Million to Address Food Insecurity - Yahoo Finance
Gilead Sciences, Inc. $GILD Shares Bought by Nemes Rush Group LLC - MarketBeat
Truist Securities assumes coverage on Gilead Sciences stock with Buy rating - Investing.com
Gilead Sciences, Inc. $GILD Shares Bought by MAI Capital Management - MarketBeat
Centric Wealth Management Purchases 2,736 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Charles Schwab Investment Management Inc. Lowers Holdings in Gilead Sciences, Inc. $GILD - MarketBeat
Sprint Bioscience Surges After Selling Cancer Program to Gilead Sciences - MarketScreener
Healthcare companies expand their 'suitcases' - ecns.cn
Sprint Bioscience sells the TREX1 program to Gilead - TradingView
Is Ameya Precision Engineers Limited a Safe Haven Stock During Market StressTrade Execution Strategies & See Risk Factors Before Making Any Move - earlytimes.in
Gilead Sciences (NASDAQ:GILD) Stock Price Expected to Rise, Mizuho Analyst Says - MarketBeat
TD Waterhouse Canada Inc. Sells 120,736 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Gilead Sciences, Inc. $GILD Shares Purchased by Rhumbline Advisers - MarketBeat
Mufg Securities Americas Inc. Grows Position in Gilead Sciences, Inc. $GILD - MarketBeat
Journey Strategic Wealth LLC Buys 4,053 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
DNB Asset Management AS Purchases 61,277 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
American Century Companies Inc. Boosts Stock Holdings in Gilead Sciences, Inc. $GILD - MarketBeat
Legal & General Group Plc Sells 487,170 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Mediolanum International Funds Ltd Purchases 82,402 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Swiss National Bank Grows Stock Position in Gilead Sciences, Inc. $GILD - MarketBeat
Handelsbanken Fonder AB Buys 69,440 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Rockefeller Capital Management L.P. Decreases Position in Gilead Sciences, Inc. $GILD - MarketBeat
CFC Planning Co LLC Buys New Stake in Gilead Sciences, Inc. $GILD - MarketBeat
Brandywine Global Investment Management LLC Sells 5,650 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
First Deliveries of Gilead's Twice-Yearly HIV Prevention Therapy in Sub-Saharah Africaand What it Means for Ending the HIV Epidemic - Gilead Sciences
Bob Allen joins Gilead’s public affairs team - PRWeek
Gilead (GILD) Unit Receives FDA Orphan Drug Designation - GuruFocus
Gilead Sciences (GILD) Receives Upgrade Amid HIV Division Streng - GuruFocus
Mizuho Adjusts Price Target on Gilead Sciences to $140 From $131, Maintains Outperform Rating - MarketScreener
Prudential PLC Sells 27,809 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Gilead abruptly parts ways with general counsel—Chutes & Ladders - Fierce Biotech
Mizuho raises Gilead Sciences stock price target to $140 on HIV outlook - Investing.com
Ensign Peak Advisors Inc Buys 152,685 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
How Gilead’s Lenacapavir Launch and New HIV Data May Shape GILD’s Global Outlook - simplywall.st
Gilead Sciences: Rating Upgrade Warranted On HIV Division Strength (GILD) - Seeking Alpha
South Africa is urged by advocates to issue a compulsory license for Gilead's HIV prevention drug - statnews.com
Gilead’s Top Lawyer Leaving After Big Stock Sale, Settlements - Bloomberg Law News
Gilead Sciences (NASDAQ:GILD) Reaches New 1-Year HighHere's What Happened - MarketBeat
Here is What to Know Beyond Why Gilead Sciences, Inc. (GILD) is a Trending Stock - Yahoo Finance
Connor Clark & Lunn Investment Management Ltd. Has $673,000 Stock Position in Gilead Sciences, Inc. $GILD - MarketBeat
Will Gilead Sciences Inc. (Common Stock) (GIS0) stock enhance shareholder value2025 Support & Resistance & Advanced Technical Signal Analysis - newser.com
Will Gilead Sciences Inc. (GIS) stock outperform energy sector in 2025Weekly Market Report & Verified Stock Trade Ideas - newser.com
Gilead Sciences (GILD): Taking Stock of Valuation as Shares Approach Analyst Targets - Yahoo Finance
Will Gilead Sciences Inc. (Common Stock) (GIS0) stock outperform Dow JonesQuarterly Trade Summary & Precise Swing Trade Alerts - newser.com
Identifying reversal signals in Gilead Sciences Inc.July 2025 Highlights & Expert Approved Momentum Ideas - newser.com
Johanna Mercier Sells 28,000 Shares of Gilead Sciences (NASDAQ:GILD) Stock - MarketBeat
Andrew Dickinson Sells 2,500 Shares of Gilead Sciences (NASDAQ:GILD) Stock - MarketBeat
Gilead Sciences Inc (GILD) 財務データ
収益
当期純利益
現金流量
EPS
Gilead Sciences Inc (GILD) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Mercier Johanna | Chief Commercial Officer |
Nov 17 '25 |
Option Exercise |
66.64 |
25,000 |
1,666,000 |
135,193 |
| Mercier Johanna | Chief Commercial Officer |
Nov 17 '25 |
Sale |
125.86 |
28,000 |
3,524,173 |
107,193 |
5.54%
0.76%
大文字化:
|
ボリューム (24 時間):